HIV vaccines - where are we going?

Abstract

Carole Heilman (Division of AIDS at the National Institutes of Allergy and Infectious Diseases) and David Baltimore (President of the California Institute of Technology) review current research efforts toward developing anti-HIV vaccines. While recognizing the extraordinary challenges involved in developing a vaccine, Heilman and Baltimore stress that important steps have been taken and that as such there is room for optimism.

Additional details